Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lupus or SLE”

102 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 102 results

Large-scale testing (Phase 3)Study completedNCT00712933
What this trial is testing

A Continuation Trial for Subjects With Lupus That Completed Protocol HGS1006-C1056 or HGS1006-C1057

Who this might be right for
Systemic Lupus Erythematosus
Human Genome Sciences Inc., a GSK Company 738
Not applicableLooking for participantsNCT05927688
What this trial is testing

Assessment of Physician Consideration of EPRO's, from Patients with Gout, Rheumatoid Arthritis, Sjogren's Syndrome or Systemic Lupus, on the Frequency of Therapeutic Adjustments

Who this might be right for
GoutRheumatoid ArthritisSjogren's Syndrome+1 more
University Hospital, Strasbourg, France 352
Very early researchLooking for participantsNCT07174843
What this trial is testing

An Exploratory Study of CD19/CD22/BCMA CAR-T Cells (BZE2204) in Subjects With Relapsed or Refractory Autoimmune Diseases

Who this might be right for
Idiopathic Inflammatory Myopathies(IIM)Immune Thrombocytopenia(ITP)Systemic Lupus Erythematosus(SLE)
Shanghai Cell Therapy Group Co.,Ltd 20
Early research (Phase 1)Looking for participantsNCT07361094
What this trial is testing

Autologous CD19/BCMA Dual-Target CAR-T for Relapsed/Refractory Autoimmune Diseases

Who this might be right for
Relapsed/Refractory Systemic Lupus ErythematosusRelapsed/Refractory Systemic SclerosisRelapsed/Refractory Idiopathic Inflammatory Myopathies+3 more
Beijing Boren Hospital 12
Testing effectiveness (Phase 2)UnknownNCT03260166
What this trial is testing

Nicotinamide Treatment for Lupus-associated Skin Lesions in Lupus Erythematosus

Who this might be right for
Cutaneous Lupus ErythematosusSystemic Lupus Erythematosus Rash
Second Xiangya Hospital of Central South University 40
Large-scale testing (Phase 3)WithdrawnNCT02074020
What this trial is testing

CHABLIS-SC2: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus With or Without Nephritis

Who this might be right for
Systemic Lupus Erythematosus
Anthera Pharmaceuticals
Not applicableLooking for participantsNCT06373081
What this trial is testing

Anti-CD19-CD3E-CAR-T Cells in Relapsed/Refractory Autoimmune Disease

Who this might be right for
Systemic Lupus Erythematosus (SLE)Sjogren's SyndromeSystemic Sclerosis+3 more
Shanghai Changzheng Hospital 6
Large-scale testing (Phase 3)Study completedNCT01551069
What this trial is testing

Multicenter Study Assessing the Efficacy & Safety of Hydroxychloroquine Sulfate in Patients With Systemic Lupus Erythematosus or Cutaneous Lupus Erythematosus With Active Lupus Erythematosus Specific Skin Lesion

Who this might be right for
Cutaneous Lupus Erythematosus-Systemic Lupus Erythematosus
Sanofi 103
Post-approval studies (Phase 4)Active Not RecruitingNCT05879419
What this trial is testing

Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases

Who this might be right for
Rheumatoid ArthritisSpondylitis, AnkylosingSpondyloarthritis+8 more
University of Sao Paulo General Hospital 2,005
Testing effectiveness (Phase 2)Ended earlyNCT05879718
What this trial is testing

Learn About the Study Medicine (PF-06823859) in Adults With Active CLE or SLE With Skin Symptoms.

Who this might be right for
Lupus Erythematosus, SystemicLupus Erythematosus, Cutaneous
Pfizer 8
Post-approval studies (Phase 4)Looking for participantsNCT07077486
What this trial is testing

Effects of Telitacicept vs Cyclophosphamide on Lupus Related Interstitial Lung Disease

Who this might be right for
Lupus or SLEInterstitial Lung DiseaseSystemic Lupus Erythematosus
Tongji Hospital 100
Testing effectiveness (Phase 2)Study completedNCT04186871
What this trial is testing

Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid Arthritis

Who this might be right for
Autoimmune DisorderRheumatoid ArthritisSystemic Lupus Erythematosus+1 more
Bristol-Myers Squibb 119
Testing effectiveness (Phase 2)Looking for participantsNCT07260877
What this trial is testing

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus

Who this might be right for
Cutaneous Lupus Erythematosus (CLE)Systemic Lupus ErythematosusSLE+2 more
Ventus Therapeutics U.S., Inc. 24
Testing effectiveness (Phase 2)Study completedNCT00979654
What this trial is testing

Evaluate the Long-Term Safety of MEDI-545 in Adult Participants With Systemic Lupus Erythematosus or Myositis

Who this might be right for
Systemic Lupus Erythematosus
MedImmune LLC 118
Large-scale testing (Phase 3)Ended earlyNCT02041091
What this trial is testing

Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus

Who this might be right for
Lupus Erythematosus, Systemic
Eli Lilly and Company 226
Testing effectiveness (Phase 2)Study completedNCT00391924
What this trial is testing

Dehydroepiandrosterone Administration in Women With Systemic Lupus Erythematosus or Primary Sjögren's Syndrome

Who this might be right for
Lupus Erythematosus, SystemicSjogren's Syndrome
UMC Utrecht 120
Large-scale testing (Phase 3)Study completedNCT05001737
What this trial is testing

Evaluate Efficacy, Safety and Tolerability, PK and PD of Emapalumab in Children and Adults With MAS in Still's or SLE

Who this might be right for
Macrophage Activation SyndromeSecondary Hemophagocytic LymphohistiocytosisStill Disease+4 more
Swedish Orphan Biovitrum 33
Early research (Phase 1)Looking for participantsNCT05869955
What this trial is testing

CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)

Who this might be right for
Systemic Lupus ErythematosusIdiopathic Inflammatory MyopathySystemic Sclerosis+1 more
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 270
Not applicableLooking for participantsNCT05635266
What this trial is testing

Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

Who this might be right for
Age-Related Macular DegenerationAllergiesAlpha-Gal Syndrome+44 more
Sanguine Biosciences 20,000
Testing effectiveness (Phase 2)Looking for participantsNCT07015983
What this trial is testing

CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)

Who this might be right for
Lupus Erythematosus, SystemicLupus Nephritis
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 89
Load More Results